What Physiq does

PhysIQ is a Chicago-based, privately held healthcare technology company founded in 2011 that applies proprietary artificial intelligence to data captured from wearable biosensors to continuously monitor patients. The company positions its platform at the intersection of digital health and clinical decision support, targeting healthcare providers and health systems that require longitudinal physiological insight outside traditional care settings.

The company is led by co-founders Gary Conkright (Chairman and CEO) and Matt Pipke (Chief Digital Health Officer), supported by a dedicated C-suite including a Chief Scientific Officer (Stephan Wegerich) and Chief Operating Officer (Joel Splan), as well as commercial leadership comprising a VP of Marketing and two SVP/GM roles with specific healthcare remit (Gary Manning; John Wilson). The firm has raised approximately $26.4 million in aggregate disclosed funding across six rounds from 2013 through 2020, with investors including 4490 Ventures (lead on the largest $8M round in 2017), LionBird, GF Securities, Quark Venture, Pioneer Healthcare Partners, 20/20 HealthCare Partners, and Purdue Foundry Investment Fund. Headcount is stated at 51–100 employees. Notably, the company's primary website (physiq.com) is currently returning a Cloudflare DNS resolution error, and the most recent disclosed funding activity dates to January 2020, creating material uncertainty about current operational scale and trajectory.

The business model and pricing structure are not publicly disclosed in available sources. Publicly referenced proprietary technology features include novel multiscale modeling architectures and digital twin frameworks; however, several of these detailed technology descriptions reference cancer drug synergy prediction and tumor-immune modeling that appear inconsistent with the wearable biosensor monitoring positioning and likely reflect data cross-attribution rather than first-party PhysIQ technology. What can be confirmed is that the firm's first-party positioning centers on proprietary AI applied to wearable biosensor data streams for continuous patient monitoring, with scientific output evidenced in Nature-indexed publications dated 2024 and 2026.

Name

Physiq

Website

https://physiq.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

51–100 employees

Short description

PhysIQ is a Chicago-based healthcare technology company founded in 2011 that applies proprietary AI to wearable biosensor data to continuously monitor patients for healthcare providers and health systems.

Ownership category

akta.pro rank

Product category

Remote Patient Monitoring Software

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)

akta.pro secondary industries

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF), Chronic Care & Remote Patient Monitoring (RPM) Platforms (HLALABAF)

Keywords

• Remote patient monitoring
• Wearable biosensor analytics
• AI healthcare platform
• Digital health monitoring
• Continuous physiological monitoring

Headquarters

HQ city

Chicago

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations

Core offering

Physiq develops and delivers a healthcare technology platform that uses proprietary artificial intelligence together with wearable biosensors to monitor patients, producing continuous physiological data and clinical insights for healthcare providers managing patients outside traditional clinical settings.

Differentiator

Problem solved

Functional benefit

Products and services

• PhysIQ AI Biosensor Patient Monitoring Platform Healthcare technology platform that pairs proprietary AI analytics with wearable biosensors to continuously monitor patients and translate physiological data into clinical insights for healthcare providers.

Quantifiable outcome

• Simulation results aligned with experimental data for drug combination predictions

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Preventice Solutions (Boston Scientific): Preventice, now part of Boston Scientific, offers BodyGuardian wearable cardiac monitors with cloud-based analytics, comparable to PhysIQ's continuous monitoring and AI analytics approach. Both target hospital systems and cardiology practices.
• Medtronic: Medtronic offers a broad portfolio of patient monitoring, implanted sensors, and remote cardiac devices with integrated analytics. It is comparable as the scaled incumbent that PhysIQ's wearable biosensor platform would compete against for hospital contracts.
• GE HealthCare: GE HealthCare provides patient monitoring solutions including wearable and bedside vital signs devices with central monitoring analytics. It is comparable as an established incumbent in clinical-grade continuous monitoring that targets the same hospital customer base as PhysIQ.
• BioTelemetry (Philips): BioTelemetry, acquired by Philips, provides remote cardiac monitoring services and connected device infrastructure for ambulatory patients. It is comparable as a scaled incumbent in wearable biosensor-driven RPM with hospital-channel reach.
• Dexcom: Dexcom manufactures continuous glucose monitoring wearable sensors with cloud-based data analytics. It is comparable as a scaled wearable biosensor company with proprietary sensor technology and AI-driven clinical insights.

Direct peers

• iRhythm Technologies: iRhythm develops wearable cardiac monitoring patches (Zio) with AI-based arrhythmia detection, directly comparable to PhysIQ's wearable biosensor patient monitoring platform. Both target continuous ambulatory monitoring with proprietary analytics for clinical decision support.
• Vivify Health: Vivify Health provides an RPM platform with connected devices and patient engagement tools for chronic care management. It is comparable to PhysIQ in combining wearable/connected biosensors with a software platform for clinical monitoring.
• Current Health: Current Health offers an FDA-cleared continuous vital signs monitoring platform with a wearable device and AI analytics for hospital-at-home and post-acute care. It directly overlaps with PhysIQ's described wearable biosensor + AI monitoring business.

Emerging players

• Tempus Labs: Tempus builds AI-driven precision medicine platforms integrating clinical and molecular data, including patient digital-twin-adjacent capabilities. It overlaps with PhysIQ's described computational modeling and digital twin work in cancer treatment.
• Health Catalyst: Health Catalyst provides healthcare data and analytics infrastructure, including real-world clinical data platforms for providers and life sciences. It is comparable to PhysIQ's data integration and clinical analytics layer of the business.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights7 records

Customer concentration

• Xx.com/physiq
• LinkedInlinkedin.com/company/physiq

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds6 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Physiq